Tag:
CPEX Pharmaceuticals
Latest Headlines
Latest Headlines
CPEX's drug-delivery technology attractive to Footstar
A unit of Footstar Corp., a holding company, has agreed to acquire CPEX Pharmaceuticals for $76.6 million in cash. The bid is worth $27.25 a share--more than twice what it was a year ago as
CPEX Pharma sells for $76M
A unit of Footstar Corp., a holding company, has agreed to acquire CPEX Pharmaceuticals for $76.6 million in cash. The bid is worth $27.25 a share, more than twice what it was a year ago as
Hostile bid gets a cold shoulder from CPEX Pharma
The board at CPEX Pharmaceuticals has rejected a hostile buyout offer of $16 a share, saying that Richard Rofe's bid undervalues the Exeter, NH-based drug delivery technology company. And at the same
